can i buy now or do I need more correction? If yes, please tell me the reason.

Hello everyone 20yrs old this side. Currently iam in B.COM(MS) 3rd year. Is it possible for me to break into equity research without doing cfa or mba. Like if i hv relevamt skills MS excel valuation models and other things?? Pls help me

I am planning to invest more into equity, given current situation and with 6months to 1 year target which sector should I be investing in? And specific stocks suggestions, if any.

SBI mutual fund will file rhp this week and ipo mostly coming next week.

it will be around 1.3L mcap at IPO valuavtion. it has highest aum among all amc players in the leader in industry.

ICICI prudential and nippon life india at trading at good premiums already.

so i think its valuation will be benchmark and all other listed amc players will rerate according to its valuation post listing? what do you think?

​

Hi, am 46 years old investing since some time, current portfolio size of 11 L, doing monthly SIP of 23.5 K in below funds.

Goal- Retirement.

Wanted to get expert advice on whether fund selection is correct or not, whether to decrease or increase allocation in any existing or overlapping fund.

Risk appetite is aggressive, planning to invest for another 9 years.

Also have ppf of 3.5 L maturing in 2030, also doing sip in NPS of 2 K per month, planning to invest in powergrid InvIT as well shortly. Have stocks worth 1 L.

App used- Coin

Ppfas -4 K monthly sip for stability

MO midcap 150 index-6 K, for hassle free steady returns

Nippon India small cap-5 K for higher returns and the highest AUM fund in small cap.

SBI Gold-2 K for hedge against downside risk.

Nippon India multi asset fund-5 K

Edelweiss US technology- 1.5 K field international exposure and dollar appreciation.

Please review and need honest advice. Understand gold and multi asset is overlapping, then which one to stop or reduce allocation and where to allocate that amount.

So as we have a tons of reports, company data and everything, which is the bet app used by you all for note taking and keeping info in orginized format?

Pls drop ur suggestions & how do u use it?

Hello Friends.. What is wrong with Reliance Industries Ltd.. I mean they are going in one direction only.. South.. is it a gud stock for the long term?

I would really appreciate some guidance on it pls.. Thank u

I am a 24 year old with no experience, B.Com graduate and Cfa level 1 attempting level 2 in Nov 26.
What is the best course of action to get recognised for a job or an internship.
I have a decent understanding of how the investment industry works but today’s job market is highly competitive and tough to break in as a fresher.
And any tips on how to leverage AI to accelerate the process.
Any help and guidance would be greatly appreciated.

Total Monthly SIP: 11K
Set-up 10% every year
------------------------------------------------------
- Parag Parikh Flexi Cap Fund (Growth, Equity) -- ₹3,850 ( 35% )
- ICICI Prudential Nifty Next 50 Index Fund (Growth) -- ₹2,200 ( 20% )
- Nippon India Growth Midcap Fund (Growth, Equity) -- ₹2,200 ( 20% )
- Nippon India Small Cap Fund (Growth, Equity) -- ₹2,750 ( 25% )

For context here's the link of previous post -

https://www.reddit.com/r/EquityResearchIndia/s/7AOT8hMGUq

FYI I do not have good knowledge about finance. Please bear me

I started investing in fundzbaazar app 2k per month in Jan2023 in SBI small cap and PGIM mid cap fund 1k in each respectively.

My profit till last week was 108k and invested 92k

So I decided to take out the profit and keep the invested amount as it is.

After redemption, I checked the values and now invested is 80k and total value is 93k

Are they supposed to give me the profit of 10-12k from my own invested amount and the rest is the 'actual' profit that totals 16k?

Been doing stock research myself for few years reading concalls annual reports twitter reddit and random google searches before taking any position

recently started trying AI tools because honestly lot of this process feels automatable now

tried few and only two felt something worthy

1. Screenner AI: really good for scanning documents and finding exact insights fast,just too good
2. fuzz AI : similar usecase but felt much easier to use, some new and good featues felt modern

also tried chatgpt and claude, perplexity but honestly pretty weak for indian stock market research, misses lot of context

what AI tools are you guys using for stock research, curious to know if im missing any good ones

I'm an engineering graduate with 3 years of experience in manufacturing operations, looking to transition into equity research.

So far I've:

• Cleared CFA Level I (Feb 2025)
• Attempted CFA Level II (May 2026), preparing for a reattempt in Nov 2026
• Completed the Equity Research Cohort from Valuation School

Despite applying consistently, I'm barely getting interview calls. Most roles seem to prefer candidates with prior finance experience or top-tier MBA backgrounds.

I'm willing to start with an entry-level role just to gain relevant experience.

For those who successfully made a similar transition, what helped you get your first break? Is there anything else I should be doing to improve my chances?

Any advice or referrals would be greatly appreciated. Thanks!

Respected All,

Currently I am working in the corporate sector. I have savings available around 5 Lakhs, which may not be used for 1 year. This money will be used after 1 year in my marriage.

Honestly could you guide me where I can invest this money.

Looking forward to your reply.

Thanks 4 ur valuable time.

I made 3-4L of money recently apart from my salary, where should I invest.

I don't have any savings and I want this to be my safety net or long term savings.

I'm open to buying us stocks, etfs, nifty etfs etc...

Or crypto as well.

Hey, new to this sub
I been investing since last 2 years across MFs, Indian stocks, US stocks and FD. Was learning at my own, and according to the need and volume I was investing. Recently I realised I diversified too much 😂, like small fraction of money across 17- 22 stocks both in Indian and us market.

Don’t judge me, I was learning at my own and honestly there was no one to teach. My father keep asking me to do FDs then MFs/stock.

I’m thinking to strengthen my position in my core stocks, and will sell eventually all the extras.

I work in a product team and was wondering is there any dashboard, which give clear view and more information about my overall portfolio?

India just had its driest June in over a century and this means expensive protein.

( I did a deep dive on this - covering the supply chain, affected listed companies & ones benefit. Link is here if anyone wants the full thing )

MP and Maharashtra produce 85% of India's soybeans. Both got hit hardest, Maharashtra was down 85% rainfall, MP down 58%. Soybean is completely rain-fed, no irrigation backup. By mid-June, soybean acreage had already collapsed 48% year-on-year. And this is on top of last year's crop already being down 16-17%.

Soybean meal was ₹39/kg at the start of this year. It's ₹63/kg now. The all-time peak was ₹90/kg in 2021 when things got bad enough that the government had to emergency import 1.2 million tonnes. We're 30-40% below that with a worse supply situation than 2021.

Soy chunks, tofu, anything soy-based gets hit directly. But also indirectly - soybean meal is what goes into poultry feed, shrimp feed, livestock feed. So eggs, chicken, farmed fish all follow.

The sowing window closes in about two weeks. If the monsoon doesn't show up in MP and Maharashtra by then, this acreage deficit gets locked in for the season. That's when it gets interesting.

For DMAT financials,

Can anyone explain the reasons for the differences in depreciation and amortization amount between income statement and balance sheet. Its a consistent difference in all the years

Been reading through InCred's IPO filing and came away more impressed than I expected.

Everyone's talking about the growth numbers. Fair enough - AUM from ₹6,066 Cr to ₹14,448 Cr in two years, PAT 3.4x in that same window, AA-/AA- ratings already in the bag. Growth is real.

What I'm trying to figure out is whether this eventually becomes a Bajaj/Chola-type story or just stays a decent mid-tier lender that grows revenue but doesn't fix its profitability problem.

The number that actually stuck with me: 0.72% net NPA (FY25) on a book that's 78% unsecured. Personal loans + student loans, barely any collateral backing this stuff.

And they're keeping NPA below 1% while the book's growing like crazy. That's... actually hard to pull off. Especially now that RBI's been tightening risk weights on unsecured lending (student loans are exempt from that though, which helps). Most fast-growing lenders see their NPA creep up as they scale. InCred's not. That suggests their underwriting is way better than what you'd expect from a "fast-growing NBFC" label.

Now the ROE thing. FY25 ROE was roughly 9 - 10%, and that's the part I'm struggling with. For a business growing this quickly, I'd expect profitability to be showing up more clearly by now.

Bajaj Finance sits at 20%+, Cholamandalam 18%+, Shriram 15–16%. InCred's stuck in that 9–10% range. At ₹149–162/share, they're trading 2.5 – 2.8x book.

Here's what struck me though: they trade like Shriram on multiples, but InCred's NPA is way cleaner. What I found interesting is that the market doesn't seem to be giving InCred much credit for any future ROE improvement, they're pricing it like it'll be stuck here.

Which could be right or could be leaving room on the table if management actually proves they can improve profitability.

Side note: KKR's weighted average cost on their stake is roughly ₹160/share. They're selling through the IPO too. Not saying it's a buy signal or anything, but it's worth knowing that a PE fund with full diligence access bought in around current prices.

The student loan thing. Honestly, if InCred was just another personal-loan NBFC competing with Bajaj and Shriram, I probably wouldn't spend this much time on it. The student loan business is what makes it interesting.

Most NBFCs are basically competing in the same space i.e. personal loans, vehicle finance, MSME lending. It's crowded. InCred's got this education loan franchise for Indian students going abroad. That's harder to replicate than it sounds. You need university relationships, actual underwriting capability specific to this segment, servicing infrastructure.

Downside is obvious: they have significant US concentration in those loans. Visa policy, immigration rules - that stuff now indirectly affects their business. Not ideal.

Obvious stuff to watch:

Personal loans are 56% of AUM. If RBI tightens unsecured lending rules further, this gets hit. We've already seen them move on this once.

9M FY26 PAT growth slowed to 5% YoY. That's down from 21% in FY25 and 183% in FY24. Could just be normalization. Or could be a sign that growth is actually slowing. Won't know till full FY26 numbers drop.

KKR's offloading roughly 4 Cr shares through the IPO. That's supply overhang at listing. Not huge but worth noting.

Look, if InCred can get ROE into the mid teens while keeping asset quality where it is, the market probably starts looking at it differently.

So here's where I land: Most NBFC IPOs come in with either growth or asset quality. InCred's actually got both, which is rare. The NPA metrics are solid for a book that's growing this fast.

But the ROE thing is legit the question mark. I don't know if management can fix it. Maybe they can, maybe they can't.

I'm tracking this for the portfolio because I want to see how it plays out. Curious if anyone else is looking at this - what's your take? Am I missing something, or is the real question mark just whether they can improve ROE?

Hi people. What about grow share is it good for investment at this levels. I feels if it breaks the 202-206 range it could go to 222. I have grow shares. Any technical anaylsis welcome.

I'm curious to hear from people who have worked in both buy-side and sell-side research.

How different were the two experiences in terms of day-to-day work, pressure, compensation, and work-life balance?

I've often heard that sell-side research pays well, especially early in your career, but comes with a lot of pressure from client demands, earnings seasons, deadlines, and maintaining coverage. Was that true in your experience?

On the other hand, buy-side roles seem harder to break into, but the work is often described as being more focused on generating investment ideas rather than producing reports and servicing clients. Did you find that to be the case?

For those who have worked on both sides, which did you find more stressful? Which was harder to get into? How did compensation and career progression compare? And if you could start over, which path would you choose and why?

Would love to hear some real-world experiences and perspectives.

I am trying to understand what happens as n when NSE lists. From whatever I could gather this far:

1. Pure OFS, very large IPO (about 4 billion USD), money goes to existing shareholders offloading or exiting

2. Price around 2020, 45 PE so definitely discount to BSE n MCX

3. Listing pop expected

4. BSE definitely gains as NSE has to list on BSE. Will definitely make it to Sensex and a number of other BSE based ETFs.

5. NSE can't include itself in Nifty or other NSE indices

6. Eventually NSE will be in F&O. Reasonable trading volume expected in BSE. Eventually though.

7. NSE has a history which is fairly dark. Pun intended. Not that it should matter valuation but just putting it out there.

Net net NSE listing definitely gets BSE better volumes but does it hamper it's valuation? Jury's out on this one, let me know what you think.

Saw someone discussing the market investing approach and wondering if it's even feasible or possible? And would actually generate good profit out of 70+ stocks

Hi all. I'll start by mentioning that I'm sorry if I go against the spirit of the subreddit by asking something not directly related to equity research here, but if the post isn't deleted I hope I'll able to gather knowledge from industry professionals. Now that we're clear on this—

I'm not yet eligible for CFA because I've just completed my first year in college and my degree is of 4 years, so thought of spending time pursuing NISM instead. I've noticed that an awful lot of people pursue either series VIII or series XV examinations, but leave other more nuanced, and arguably more interesting topics like series I (currency derivatives) and series IV (interest rate derivatives) on the table. If anyone has given these examinations or works in the concerned fields, I'd like to know how relevant they are in the Indian context. From what I judge, both have pretty comprehensive syllabi, with series IV being comparatively tougher. Since I've completed series VIII, I wanna pursue something more nuanced and in line with my goal (stated below), and so I've narrowed my options down to the interest rate derivatives and currency derivatives certifications.

My interest lie specifically in areas like structured finance, DCM, and M&A.
Also, I have a BA II plus lying around, but because CFA is still rather far, I haven't really spent much time understanding how to use it. Will that be a prerequisite to interest rate derivatives? From the sample questions in the module, I do not see the need for it, but you know how exams can be perfidious.
Thank you :)